ENCORIUM GROUP INC 4
4 · ENCORIUM GROUP INC · Filed Jul 30, 2007
Insider Transaction Report
Form 4
Manninen Petri Mikael
Director
Transactions
- Exercise/Conversion
stock option
2007-07-25−48,099→ 0 totalExercise: $2.57From: 2006-11-01Exp: 2009-01-31→ common stock (48,099 underlying) - Exercise/Conversion
common stock
2007-07-25$2.57/sh+48,099$123,614→ 48,099 total
Holdings
- 273,403(indirect: managing director of NTGLT Pharma BVBA)
common stock
Footnotes (4)
- [F1]Prior to the Company's acquisition of Remedium on November 1, 2006, Mr. Manninen held an option to purchase 120 shares of Remedium. Pursuant to the terms of an option exchange agreement, upon the consummation of the Company's acquisition of Remedium on November 1, 2006, the option held by Mr. Manninen remained outstanding. Upon exercise, however, Mr. Manninen became entitled to receive approximately 400.82 Encorium shares for each Remedium share otherwise issuable upon the exercise of a Remedium option (or approximately 48,099 shares of Encorium stock) at an excercise price of 750 EUR per Remedium share. The EUR 750 exercise price per Remedium share represented an exercise price per Encorium share of $2.57, based on the exchange rate into the U.S. Dollar of the Euro designated by the Federal Reserve Bank of New York as of July 25, 2007.
- [F2]See Footnote 1.
- [F3]See Footnote 1.
- [F4]See Footnote 1.